Usefulness of indigo carmine chromoendoscopy for detecting gastric cancer and gastric adenoma during upper gastrointestinal endoscopy (INDIGO study): protocol for a prospective multicentre observational study

• by Takeshi Yasuda, Jun Matsubayashi, Hideki Ishikawa, Kohei Takizawa

• July 1, 2026

Artificial intelligence for triple-negative breast cancer from imaging to multi-omics

• by Xing Peng, Xinyu Zhou, Xin Feng, Nimin Fang, Xiaoya Dong, Wanjing Hong, Tianli Li, Renxing Li, Mohammad Faidzul Nasrudin

• June 30, 2026

Development and application of a prognostic model based on radiomics and artificial intelligence for patients with lung adenocarcinoma brain metastasis

• by Congying Zheng, Xinyuan Yang, Musen Ye, Kai Tang, Shubin Wang

• June 30, 2026

ASCO26: Sara Tolaney, MD, MPH, ASCENT-04

Dana-Farber Cancer Institute's Dr. Sara Tolaney presented a subgroup analysis of the ASCENT-04 study based on biomarkers. Across all subgroups, patients who received sacituzumab govitecan plus pembro as first-line therapy had longer progression-free survival compared to standard therapy.

• July 1, 2026

• 1 min